Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels

DNA Repair

Volumn 23, Issue , 2014, Pages 33-38

  Skoge, Renate Hvidsten ^a   Dölle, Christian ^a   Ziegler, Mathias ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

NAD metabolism; NAD dependent deacetylation; Sirtuin; Tubulin acetylation

Indexed keywords

ALPHA TUBULIN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SIRTUIN 2; TUBULIN; ACRYLAMIDE DERIVATIVE; ENZYME INHIBITOR; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; LYSINE; N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE; N-(OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)-N,N-DIMETHYLACETAMIDE HYDROCHLORIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; PHENANTHRENE DERIVATIVE; PIPERIDINE DERIVATIVE; SIRT2 PROTEIN, HUMAN; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CELL LEVEL; DEACETYLATION; ENZYME BLOOD LEVEL; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM;

ACETYLATION; ACRYLAMIDES; ENZYME INHIBITORS; HEK293 CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; LYSINE; NAD; PHENANTHRENES; PIPERIDINES; POLY(ADP-RIBOSE) POLYMERASES; SIRTUIN 2; TUBULIN;

EID: 84917671255     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.04.011     Document Type: Article

References (41)

1. Janke C., Bulinski J.C. Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat. Rev. Mol. Cell Biol. 2011, 12:773-786.
2. Nogales E. Structural insights into microtubule function. Annu. Rev. Biochem. 2000, 69:277-302.
3. Al-Bassam J., Corbett K.D. Alpha-tubulin acetylation from the inside out. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:19515-19516.
4. Piperno G., LeDizet M., Chang X.J. Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J. Cell Biol. 1987, 104:289-302.
5. Cueva J.G., Hsin J., Huang K.C., Goodman M.B. Posttranslational acetylation of alpha-tubulin constrains protofilament number in native microtubules. Curr. Biol.: CB 2012, 22:1066-1074.
6. Dompierre J.P., Godin J.D., Charrin B.C., Cordelieres F.P., King S.J., Humbert S., Saudou F. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci.: Off. J. Soc. Neurosci. 2007, 27:3571-3583.
7. Reed N.A., Cai D., Blasius T.L., Jih G.T., Meyhofer E., Gaertig J., Verhey K.J. Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol.: CB 2006, 16:2166-2172.
8. Kalebic N., Sorrentino S., Perlas E., Bolasco G., Martinez C., Heppenstall P.A. alphaTAT1 is the major alpha-tubulin acetyltransferase in mice. Nat. Commun. 2013, 4:1962.
9. Akella J.S., Wloga D., Kim J., Starostina N.G., Lyons-Abbott S., Morrissette N.S., Dougan S.T., Kipreos E.T., Gaertig J. MEC-17 is an alpha-tubulin acetyltransferase. Nature 2010, 467. 218-U111.
10. Nogales E., Whittaker M., Milligan R.A., Downing K.H. High-resolution model of the microtubule. Cell 1999, 96:79-88.
11. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417:455-458.
12. Matsuyama A., Shimazu T., Sumida Y., Saito A., Yoshimatsu Y., Seigneurin-Berny D., Osada H., Komatsu Y., Nishino N., Khochbin S., Horinouchi S., Yoshida M. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 2002, 21:6820-6831.
13. +-dependent tubulin deacetylase. Mol. Cell 2003, 11:437-444.
14. Vaquero A., Scher M.B., Lee D.H., Sutton A., Cheng H.L., Alt F.W., Serrano L., Sternglanz R., Reinberg D. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 2006, 20:1256-1261.
15. Rack J.G., Vanlinden M.R., Lutter T., Aasland R., Ziegler M. Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform. J. Mol. Biol. 2013, 426:1677-1691.
16. Jing E., Gesta S., Kahn C.R. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 2007, 6:105-114.
17. Rothgiesser K.M., Erener S., Waibel S., Luscher B., Hottiger M.O. SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310. J. Cell Sci. 2010, 123:4251-4258.
18. Jiang W., Wang S., Xiao M., Lin Y., Zhou L., Lei Q., Xiong Y., Guan K.L., Zhao S. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 2011, 43:33-44.
19. Snider N.T., Leonard J.M., Kwan R., Griggs N.W., Rui L., Omary M.B. Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation. J. Cell Biol. 2013, 200:241-247.
20. Revollo J.R., Grimm A.A., Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 2004, 279:50754-50763.
21. + metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
22. Dolle C., Skoge R.H., Vanlinden M.R., Ziegler M. NAD biosynthesis in humans - enzymes, metabolites and therapeutic aspects. Curr. Top. Med. Chem. 2013, 13:2907-2917.
23. Canto C., Houtkooper R.H., Pirinen E., Youn D.Y., Oosterveer M.H., Cen Y., Fernandez-Marcos P.J., Yamamoto H., Andreux P.A., Cettour-Rose P., Gademann K., Rinsch C., Schoonjans K., Sauve A.A., Auwerx J. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012, 15:838-847.
24. Hara N., Yamada K., Shibata T., Osago H., Hashimoto T., Tsuchiya M. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J. Biol. Chem. 2007, 282:24574-24582.
25. Nikiforov A., Dolle C., Niere M., Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 2011, 286:21767-21778.
26. + biosynthesis in FK866-treated tumor cells. J. Biol. Chem. 2013, 288:25938-25949.
27. Zhao Y., Jin J., Hu Q., Zhou H.M., Yi J., Yu Z., Xu L., Wang X., Yang Y., Loscalzo J. Genetically encoded fluorescent sensors for intracellular NADH detection. Cell Metab. 2011, 14:555-566.
28. Hasmann M., Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003, 63:7436-7442.
29. Khan J.A., Tao X., Tong L. Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat. Struct. Mol. Biol. 2006, 13:582-588.
30. Galli U., Travelli C., Massarotti A., Fakhfouri G., Rahimian R., Tron G.C., Genazzani A.A. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J. Med. Chem. 2013, 56:6279-6296.
31. Bai P., Canto C., Oudart H., Brunyanszki A., Cen Y., Thomas C., Yamamoto H., Huber A., Kiss B., Houtkooper R.H., Schoonjans K., Schreiber V., Sauve A.A., Menissier-de Murcia J., Auwerx J. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011, 13:461-468.
32. + depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. PLoS ONE 2009, 4:e7897.
33. Garavaglia S., Bruzzone S., Cassani C., Canella L., Allegrone G., Sturla L., Mannino E., Millo E., De Flora A., Rizzi M. The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem. J. 2012, 441:131-141.
34. + biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J. Biol. Chem. 2013, 288:3500-3511.
35. Billington R.A., Genazzani A.A., Travelli C., Condorelli F. NAD depletion by FK866 induces autophagy. Autophagy 2008, 4:385-387.
36. Yoshino J., Mills K.F., Yoon M.J., Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011, 14:528-536.
37. Caton P.W., Kieswich J., Yaqoob M.M., Holness M.J., Sugden M.C. Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function. Diabetologia 2011, 54:3083-3092.
38. + cycle drives mitochondrial oxidative metabolism in mice. Science 2013, 342:1243417.
39. Nagai T., Ikeda M., Chiba S., Kanno S., Mizuno K. Furry promotes acetylation of microtubules in the mitotic spindle by inhibition of SIRT2 tubulin deacetylase. J. Cell Sci. 2013, 126:4369-4380.
40. Inoue T., Hiratsuka M., Osaki M., Yamada H., Kishimoto I., Yamaguchi S., Nakano S., Katoh M., Ito H., Oshimura M. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene 2007, 26:945-957.
41. Muruganandham M., Alfieri A.A., Matei C., Chen Y., Sukenick G., Schemainda I., Hasmann M., Saltz L.B., Koutcher J.A. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2005, 11:3503-3513.